Bortezomib For Injection Is Used To Treat Certain Types Of Cancer, Such As Multiple Myeloma And Mantle Cell Lymphoma Zydus Lifesciences Ltd Has Received Final Approval From The United States Food And Drug Administration (Usfda) To Market Bortezomib For Injection, 3.5 Mg/Vial, Single-Dose Vial (Usrld: Velcade) Bortezomib For Injection Is Used To Treat Certain Types Of Cancer, Such As Multiple Myeloma And Mantle Cell Lymphoma. The Medication Works By Slowing Or Stopping The Growth Of Cancer Cells. The Drug Will Be Manufactured By Zydus Hospira. Velcade Has A Market Size Of Usd 1,172 Million (As Per Iqvia Mat Mar
